All patients self-identified as non-White and nearly 69% of treated subjects had objectively measured Fitzpatrick skin types IV through VI The IL-23 inhibitor guselkumab demonstrated efficacy out to 100 weeks in the treatment of psoriasis across a spectrum of skin types, according to poster research presented at the 2026 annual meeting of the American Academy of Dermatology (AAD) in Denver. A full report will be published in the June 2026 issue of The Chronicle of Skin & Alle

Second-degree burn wound after two days of healing. Phot by Cjr80 via Wikimedia Commons A topical gel formulation of 4-aminopyridine (4-AP) for the treatment of burn wounds has achieved near-complete closure within 21 days in animal models. The findings were published in the journal Biomaterials. Researchers at the Terasaki Institute for Biomedical Innovation and the University of Arizona College of Medicine have developed the new formulation. The medication is best known und

Patients with AD have an increased risk of retinal detachment and postoperative PVR.

Photo by G.steph.rocket via Wikimedia Commons Study shows positive effects of diet on normal-weight patients with psoriasis A healthy diet is widely considered to play a role in improving psoriasis symptoms, supporting the anti-inflammatory benefits of weight loss in overweight or obese psoriasis patients, but there are benefits independent of weight loss seen in patients of all body weights. That’s according to Dr. Javier Perez-Bootelloof, Hospital Universitario Ramón y Caja

Photo by James Heilman, MD via Wikimedia Commons New research shows that adults with atopic dermatitis (AD), particularly those with childhood onset, report significantly greater limitations in their educational and professional choices. Investigators found that up to 38% of childhood-onset patients reported career restrictions and more than 36% reporting constrained study choices, compared to individuals whose disease began in adulthood. The authors say their findings, publi

Researchers have developed a minimally invasive 'intelligent tattoo' for the early detection of melanoma.

The Chronicle of Skin & Allergy, in partnership with the Dermatology Industry Taskforce on Inclusion, Diversity and Equity (DiTiDE), is pleased to announce the winners of the 4rd annual short essay competition for Canadian dermatology residents. This contest was open to any resident enrolled in a dermatology training program at a Canadian medical school, with enrolment confirmed by their Program Director. Entrants submitted a 350- to 500-word composition reflecting their view

A highly magnified view of melanoma tumours growing in the skin. CD169+ macrophages are shown in green and yellow, forming a biological boundary wall to contain the tumours. Image courtesy Garvan Institute of Medical Research For the first time, researchers have observed macrophages attacking melanoma cells in real time and identified a subpopulation of the immune cells involved in resisting the skin cancer. The findings, published in the Journal of Experimental Medicine, rev